Table 3.
Association between clinical status of ACL during surgery with histopathological changes of ACL
| Histopathologic situation |
Normal ACL
Number/percent |
Attenuated ACL
Number/percent |
P value | |
|---|---|---|---|---|
| Myxoid change | Absence(0) | 1(3.12) | 4(12.90) | 0.357 |
| Mild(1) | 23(71.87) | 19(61.29) | ||
| Moderate(2) | 7(21.87) | 8(25.80) | ||
| Marked(3) | 1(3.12) | 0(0) | ||
| Cystic myxoid or microcycystic formation | Absence(0) | 7(21.87) | 6(19.35) | 0.372 |
| Mild(1) | 9(28.12) | 14(45.16) | ||
| Moderate(2) | 12(37.5) | 10(32.25) | ||
| Marked(3) | 4(12.5) | 1(3.22) | ||
| Chondroid metaplasia | Absence(0) | 26(81.25) | 28(90.32) | 0.217 |
| Mild(1) | 6(18.75) | 2(6.45) | ||
| Moderate(2) | 0(0) | 1(3.22) | ||
| Marked(3) | 0(0) | 0(0) | ||
| acellular zone | Absence(0) | 28(87.5) | 28(90.32) | 0.5 |
| Mild(1) | 4(12.5) | 3(9.67) | ||
| Moderate(2) | 0(0) | 0(0) | ||
| Marked(3) | 0(0) | 0(0) | ||
| Vascular proliferation | Absence(0) | 15(46.87) | 15(48.38) | 0.420 0.42 |
| Mild(1) | 10(31.25) | 11(35.48) | ||
| Moderate(2) | 7(21.87) | 2(6.45) | ||
| Marked(3) | 0(0) | 0(0) | ||
| Fibroblast proliferation | Absence(0) | 25(87.12) | 28(90.32) | 0.341 |
| Mild(1) | 6(18.75) | 3(9.67) | ||
| Moderate(2) | 1(3.12) | 0(0) | ||
| Marked(3) | 0(0) | 0(0) | ||
| Calcium pyrophosphate deposits | Absence(0) | 31(96.87) | 31(100) | 0.5 |
| Mild(1) | 1(3.12) | 0(0) | ||
| Moderate(2) | 0(0) | 0(0) | ||
| Marked(3) | 0(0) | 0(0) | ||
| Presence of gout | Absence(0) | 32(100) | 31(100) | >0.05 |
| Mild(1) | 0(0) | 0(0) | ||
| Moderate(2) | 0(0) | 0(0) | ||
| Marked(3) | 0(0) | 0(0) | ||